This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Solvay Pharmaceuticals, B.v.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Annamaria Lilienkampf: Innovator in Pharmaceutical Research
Introduction
Annamaria Lilienkampf is a notable inventor based in Helsinki, Finland. She has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target specific enzymes related to steroid hormone-dependent disorders.
Latest Patents
Annamaria holds a patent for "Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds." This innovative patent focuses on thiophenepyrimidinone compounds that are useful in therapy, especially for the treatment and prevention of steroid hormone-dependent diseases. The patent specifically addresses the inhibition of the 17β-hydroxysteroid dehydrogenase (17β-HSD) enzymes, including types 1, 2, and 3.
Career Highlights
Annamaria is currently employed at Solvay Pharmaceuticals B.V., where she continues to advance her research in the pharmaceutical sector. Her work is pivotal in developing new therapeutic options for patients suffering from hormone-related disorders.
Collaborations
Annamaria collaborates with esteemed colleagues, including Kristiina Waehaelae and Sari Alho, who contribute to her research efforts and enhance the innovative environment at Solvay Pharmaceuticals.
Conclusion
Annamaria Lilienkampf's contributions to pharmaceutical research exemplify the impact of innovation in healthcare. Her work on thiophenepyrimidinone compounds represents a significant advancement in the treatment of steroid hormone-dependent disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile